Synthetic isoforms of endogenous sulfatides differently modulate indoleamine 2,3-dioxygenase in antigen presenting cells

Life Sciences

Volumn 89, Issue 5-6, 2011, Pages 176-181

  Altomare, Emanuela ^a   Fallarini, Silvia ^a   Battaglini, Carolina Orsi ^a   Mossotti, Matteo ^a   Panza, Luigi ^a   Lombardi, Grazia ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Glycosphingolipids; L kynurenine pathway; THP 1 cells; Tryptophan metabolism

Indexed keywords

GAMMA INTERFERON; I KAPPA B; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; MESSENGER RNA; SATURATED FATTY ACID; SULFATIDE;

ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; DNA BINDING; DRUG EFFECT; ENZYME ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION;

EID: 80051789063     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.05.015     Document Type: Article

References (40)

1. Beutelspacher SC, Pillai R, Watson MP, Tan PH, Tsang J, McClure MO, et al. Function of indoleamine 2, 3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur J Immunol 2006;36:690-700.
2. Blomqvist M, Rhost S, Teneberg S, Löfbom L, Osterbye T, Brigl M, et al. Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells. Eur J Immunol 2009;39:1726-35.
3. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
4. Braun D, Longman RS, Albert ML. A two-step induction of indoleamine 2, 3 dioxygenase (IDO) activity during dendritic-cell maturation. Blood 2005;106:2375-81. (Pubitemid 41510810)
5. Di Pucchio T, Danese S, De Cristofaro R, Rutella S. Inhibitors ofindoleamine 2, 3-dioxygenase: a review of novel patented lead compounds. Expert Opin Ther Pat 2010;20:229-50.
6. Du MX, Sotero-Esteva WD, Taylor MW. Analysis of transcription factors regulating induction of indoleamine 2, 3-dioxygenase by IFN-gamma. J Interferon Cytokine Res 2000;20:133-42. (Pubitemid 30123741)
7. Edling Y, Sivertsson LK, Butura A, Ingelman-Sundberg M, Ek M. Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model. Toxicol In Vitro 2009;23:1387-95.
8. Fallarini S, Paoletti T, Panza L, Lombardi G. Alpha-galactosylceramide modulates the induction of indoleamine 2, 3-dioxygenase in antigen presenting cells. Biochem Pharmacol 2008;76:738-50.
9. Fujigaki H, Saito K, Fujigaki S, Takemura M, Sudo K, Ishiguro H, et al. The signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 are not essential for the induction of indoleamine 2, 3-dioxygenase by lipopoly-saccharide: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB pathways, and synergistic effect of several proinflammatory cytokines. J Biochem 2006;139:655-62. (Pubitemid 43973911)
10. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16:225-60. (Pubitemid 28183365)
11. Grohmann U, Fallarino F, Bianchi R, Orabona C, Vacca C, Fioretti MC, et al. A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J Exp Med 2003;198:153-60. (Pubitemid 36870195)
12. Gurtner GJ, Newberry RD, Schloemann SR, McDonald KG, Stenson WF. Inhibition of indoleamine 2, 3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice. Gastroenterology 2003;125:1762-73. (Pubitemid 37500441)
13. Hayashi T, Beck L, Rossetto C, Gong X, Takikawa O, Takabayashi K, et al. Inhibition of experimental asthma by indoleamine 2, 3-dioxygenase. J Clin Invest 2004;114: 270-9. (Pubitemid 39071632)
14. Hommelberg PP, Plat J, Langen RC, Schols AM, Mensink RP. Fatty acid-induced NF-kappaB activation and insulin resistance in skeletal muscle are chain length dependent. Am J Physiol Endocrinol Metab 2009;296:E114-20.
15. Hong S, Scherer DC, Singh N, Mendiratta SK, Serizawa I, Koezuka Y, et al. Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice. Immunol Rev 1999;169:31-44. (Pubitemid 29338721)
16. Ishizuka I. Chemistry and functional distribution of sulfoglycolipids. Prog Lipid Res 1997;36:245-319. (Pubitemid 28132555)
17. Jeon SB, Yoon HJ, Park SH, Kim IH, Park EJ. Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells. J Immunol 2008;181:8077-87.
18. Jung ID, Lee CM, Jeong YI, Lee JS, Park WS, Han J, et al. Differential regulation of indoleamine 2, 3-dioxygenase by lipopolysaccharide and interferon gamma in murine bone marrow derived dendritic cells. FEBS Lett 2007;581:1449-56. (Pubitemid 46463960)
19. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997;278:1626-9. (Pubitemid 27516282)
20. King NJ, Thomas SR. Molecules in focus: indoleamine 2, 3-dioxygenase. Int J Biochem Cell Biol 2007;39:2167-72.
21. Kobayashi E, Motoki K, Uchida T, Fukushima H, Koezuka Y. KRN7000, a novel immunomodulator, and its antitumor activities. Oncol Res 1995;7:529-34. (Pubitemid 26077987)
22. Löb S, Königsrainer A, Rammensee HG, Opelz G, Terness P. Inhibitors of indoleamine-2, 3-dioxygenase for cancer therapy: can we see the wood for the trees? Nat Rev Cancer 2009;9:445-52.
23. Macchiarulo A, Camaioni E, Nuti R, Pellicciari R. Highlights at the gate of tryptophan catabolism: a review on the mechanism of activation and regulation of indolaemine 2, 3-dioxygenase (IDO), a novel target in cancer disease. Amino Acids 2009;37: 219-29.
24. MacKenzie CR, Heseler K, Müller A, Däubener W. Role of indoleamine 2, 3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines. Curr Drug Metab 2007;8:237-44. (Pubitemid 46621673)
25. Menkes JH, Philippart M, Concone MC. Concentration and fatty acid composition of cerebrosides and sulfatides in mature and immature human brain. J Lipid Res 1966;7:479-86.
26. Michieletti M, Sillani L, Panza L. A properly protected sphingosine acceptor for Helferich glycosylation. Synlett 2009;16:2609-12.
27. Munn DH, Mellor AL. Indoleamine 2, 3-dioxygenase and tumor-induced tolerance. J Clin Invest 2007;117:1147-54.
28. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998;281:1191-3. (Pubitemid 28406294)
29. Nickel E, Nienhaus K, Lu C, Yeh S-R, Nienhaus GU. Ligand and substrate migration in human indoleamine 2, 3-dioxygenase. J Biol Chem 2009;284:31548-54.
30. Pinto SN, Silva LC, de Almeida RF, Prieto M. Membrane domain formation, interdigitation, and morphological alterations induced by the very long chain asymmetric C24:1 ceramide. Biophys J 2008;95:2867-79.
31. Roeske-Nielsen A, Dalgaard LT, Månsson JE, Buschard K. The glycolipid sulfatide protects insulin-producing cells against cytokine-induced apoptosis, a possible role in diabetes. Diabetes Metab Res Rev 2010;26:631-8.
32. Ryan JM, Barry F, Murphy JM, Mahon BP. Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 2007;149:353-63. (Pubitemid 47063057)
33. SakuraiK, Zou JP, Tschetter JR, Ward JM, Shearer GM. Effectof indoleamine 2, 3-dioxygenase on induction of experimental autoimmune encephalomyelitis. J Neuroimmunol 2002;129:186-96. (Pubitemid 34874924)
34. Senn JJ. Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes. J Biol Chem 2006;281:26865-75. (Pubitemid 44401715)
35. 2 incorporation by a heme-containing dioxygenase. PNAS 2006;103:2611-6.
36. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335-76. (Pubitemid 37174535)
37. Turutin DV, Kubareva EA, Pushkareva MA, Ullrich V. Sud'ina GF. Activation of NF-kappa B transcription factor in human neutrophils by sulphatides and L-selectin cross-linking. FEBS Lett 2003;536:241-5. (Pubitemid 36206439)
38. Ueno A, Cho S, Cheng L, Wang J, Hou S, Nakano H, et al. Transient upregulation of indoleamine 2, 3-dioxygenase in dendritic cells by human chorionic gonadotropin downregulates autoimmune diabetes. Diabetes 2007;56:1686-93. (Pubitemid 46842605)
39. Vos JP, Lopes-Cardozo M, Gadella BM. Metabolic and functional aspects of sulfoga-lactolipids. Biochim Biophys Acta 1994;1211:125-49.
40. Zhou H, Yan Y, Xu G, Zhou B, Wen H, Guo D, et al. Toll-like receptor (TLR)-4 mediates anti-β2GPI/β2GPI-induced tissue factor expression in THP-1cells. Clin Exp Immunol 2011;163:189-98.